Figure 1. (a) Surveillance FDG PET/CT performed 3 d after the first dose of the Oxford-AstraZeneca COVID-19 vaccine shows FDG avidity in abdominal lymph nodes. (b) Increased FDG uptake in left lower cervical lymph nodes (SUVmax 3.5 g/ml). (c) Subcentimetric mesenteric lymph nodes with moderate FDG uptake 3 d (SUV max 4.7 g/ml).
Figure 2. (a,b,c) Follow-up FDG PET/CT 8 weeks after vaccination reveals normalization of FDG uptake in cervical (yellow arrow) and abdominal lymph nodes.
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
